Table 1. Demographic data, preoperative and postoperative best-corrected visual acuity (BCVA) and anti-glaucoma medication score, and type of glaucoma in both groups.
| Group A | Group B | P-value | |
|---|---|---|---|
| Age in years (range (mean±SD)) | 15–65 (48.44±3.48) | 34–69 (54.73±2.06) | 0.156 |
| Gender (males) (No. (%)) | 12 (66.7%) | 10 (45.5%) | 0.180 |
| Preoperative BCVA LogMAR (range (mean±SD)) | 0.8–0.1 (0.3±0.0) | 0.4–0.1 (0.2±0.0) | 0.906 |
| Postoperative BCVA LogMAR (range (mean±SD)) | 0.8–0.1 (0.3±0.0) | 0.4–0.1 (0.2±0.0) | 0.906 |
| Preoperative medscore (No. (%)) | |||
| 0 | 0% | 0% | 0.002 |
| 1 | 4 (22.2%) | 0% | |
| 2 | 14 (77.8%) | 16 (72.7%) | |
| 3 | 0% | 6 (27.3%) | |
| Postoperative medscore (No. (%)) | |||
| 0 | 18 (100%) | 16 (72.7%) | 0.024 |
| 1 | 0% | 6 (27.3%) | |
| 2 | 0% | 0% | |
| 3 | 0% | 0% | |
| Type of glaucoma (No. (%)) | Angle recession: 6 (33.3%) | Neovascular: 4 (18.2%) | |
| Pseudoexfoliation: 12 (66.7%) | Inflammatory: 6 (27.3%) | ||
| Traumatic: 12 (54.5%) |
P-value <0.05 is considered statistically significant. Bold and italic values are statistically significant.